Getting at the Heart of MRIs
For people with heart disease, a new imaging technology, multitasking MRI, may yield better results and a more comfortable experience. We asked the technique's innovator Cedars-Sinai's Anthony Christodoulou about this new technology.
Cedars-Sinai Blog / Mar 09, 2020
New Clinical Trial at Cedars-Sinai for Active Surveillance of Thyroid Tumors ...
Statistically, the incidence of thyroid cancer has increased worldwide over the past few decades, but researchers are unsure if it's an uptick in the prevalence of thyroid cancer or an increase in detection. A new clinical trial aims to ...
Cedars-Sinai Blog / Mar 04, 2020
Cedars-Sinai Investigators Exploring the Connection Between the Microbiome ...
Research have come a long way in understanding how changes in our microbiome, specifically gut bacteria, may correlate to certain diseases like diabetes. Now, researcher Ruchi Mathur, MD, at Cedars-Sinai is investigating how Type 2 ...
Cedars-Sinai Blog / Mar 03, 2020
New Research Explores Link Among Diabetes, Pancreatitis and Pancreatic Cancer...
When Type 2 diabetes is the diagnosis, physicians rarely think chronic pancreatitis is the cause. However, chronic pancreatitis may be more prevalent than many doctors think. Investigators at Cedars-Sinai are part of multicenter trials ...
Cedars-Sinai Blog / Feb 18, 2020
Gateway to the Brain
While building a brain capable of powering Frankenstein’s monster remains out of reach, Cedars-Sinai scientists have re-created a critical component—the blood-brain barrier, outside the body!
Discoveries / Feb 17, 2020
GH Therapy a Potential Risk to Older Adults
Shlomo Melmed, MB, ChB, cautions against Growth Hormone therapy in individuals who are not Growth Hormone-deficient citing concerns that GH therapy is being prescribed to older adults, ignoring the serious risks associated with this ...
Cedars-Sinai Blog / Jan 15, 2020
After Decades of Research, New Clinical Trial for Cushing's Disease | ...
Starting in 2001, Ning-Ai Liu, MD, PhD, along with other Cedars-Sinai investigators, began establishing a zebrafish model for pituitary drug testing for Cushing's disease because they have a genome that is highly homologous to humans.
Cedars-Sinai Blog / Jan 15, 2020
Cedars-Sinai Researchers May Revolutionize How Orthopaedic Injuries Are ...
Researchers at Cedars-Sinai may soon revolutionize how severe orthopaedic injuries are treated by harnessing the power of stem cells, gene therapy and ultrasound.
Cedars-Sinai Blog / Jan 15, 2020
No-Fun Fungus: Head and Shoulders and Gut
Dandruff linked to Crohn’s disease.
Discoveries / Dec 19, 2019
Making Birth Better: Kimberly Gregory, MD, MPH
Kimberly Gregory, MD, MPH, is on a professional mission to make childbirth a safer and more fulfilling experience—not just for her own patients, but for all women.
Discoveries / Dec 17, 2019
New Approaches to Pancreatic Cancer Care
Every day, about 1,300 people around the world are diagnosed with pancreatic cancer. At Cedars-Sinai, clinicians are taking novel approaches not only to attack the disease, but to improve patients' quality of life during treatment.
Cedars-Sinai Blog / Nov 12, 2019
Could Smell Impact Metabolism?
There could be a relationship between your nose and your weight.
Discoveries / Aug 06, 2019
What Do We Know About the Keto Diet?
By now you've likely heard of the ketogenic, or keto diet. Your friends swear by it and are showing great results from it. But what is keto and is it safe?
Cedars-Sinai Blog / Jul 31, 2019
Scientific Dream Team Aims to Make Preeclampsia a Relic of the Past | ...
The pregnancy disorder preeclampsia can strike in a flash, endangering both mother and child. A dream team at Cedars-Sinai is determined to render this disease—a leading cause of maternal mortality—a relic of the past.
Discoveries / Jul 01, 2019
Could Walnuts Prove Beneficial for Prostate Cancer Patients?
Researchers are taking aim at prostate cancer, a cancer that affects 1 in 9 men. Led by Dr. Stephen Freedland, the Walnuts for Power study is looking at one potential way to limit the progression.
Cedars-Sinai Blog / Jun 27, 2019
